Gene · 8542
Papers3,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| HIV-associated nephropathy: A decade of clinical outcomes, global disparities and emerging promise. | HIV Med | 2026 | 42808260 | PubTator, text mining | PubMed |
| Autophagy and Mitophagy in Hypertensive Chronic Kidney Disease: Evidence Grading, Cell-Type Divergence, and a Working Lysosomal Hypothesis. | Life (Basel) | 2026 | 42795346 | PubTator, text mining | PubMed |
| APOL1, HIV, and Pregnancy Complications: Converging Risks for Kidney Disease. | Kidney360 | 2026 | 42782823 | PubTator, text mining | PubMed |
| The APOL1 protective M1 modifier occurs exclusively with the KIK protein haplotype to suppress channel conductance. | medRxiv | 2026 | 42779842 | PubTator, text mining | PubMed |
| Blood pressure and APOL1 risk variants in a South African chronic haemodialysis population of African ancestry. | Clin Kidney J | 2026 | 42761223 | PubTator, text mining | PubMed |
| Coding, modifier, and regulatory effects shape circulating APOL1 levels. | Hum Mol Genet | 2026 | 42758720 | PubTator, text mining | PubMed |
| Differential regulation of basal and interferon-induced APOL1 gene expression in podocytes. | Am J Physiol Renal Physiol | 2026 | 42734476 | PubTator, text mining | PubMed |
| Sports Nephrology: Managing Hypertension, Acute Kidney Injury, and Cardiovascular Risk in a Collegiate Football Player. | JACC Case Rep | 2026 | 42726044 | PubTator, text mining | PubMed |
| APOL1 kidney disease: a critical narrative review of molecular mechanisms, clinical heterogeneity, and the emerging therapeutic landscape. | Int Urol Nephrol | 2026 | 42709370 | PubTator, text mining | PubMed |
| Beyond Genotype: Proteomic Risk Stratification for APOL1-Mediated Kidney Disease. | Am J Kidney Dis | 2026 | 42705445 | PubTator, text mining | PubMed |
| An integrative review of APOL1 kidney disease with a focus on the Brazilian population. | Clinics (Sao Paulo) | 2026 | 42700542 | PubTator, text mining | PubMed |
| Specific aspects of kidney care for Africans living in Europe. | Nephrol Dial Transplant | 2026 | 42690062 | PubTator, text mining | PubMed |
| Apolipoprotein L1 risk genotypes and odds of lupus nephritis-associated kidney failure in systemic lupus erythematosus: a systematic review and meta-analysis. | Front Med (Lausanne) | 2026 | 42688565 | PubTator, text mining | PubMed |
| Genomic Landscape of Systemic Lupus Erythematosus and Lupus Nephritis Globally and the Gaps in Africa. | Int J Mol Sci | 2026 | 42653386 | PubTator, text mining | PubMed |
Dietary patterns, blood pressure and proteinuria in West Africans with chronic kidney disease. Analysis from a West African CKD cohort: the Diet, Chronic Kidney Disease and Apolipoprotein L1 (DCA) Study. | Nutr Metab Cardiovasc Dis | 2026 | 42629212 | PubTator, text mining | PubMed |
| DIA proteomics of FFPE renal biopsies reveals two molecular subtypes of lupus nephritis and identifies APOL1 as candidate biomarker for stratification. | Lupus Sci Med | 2026 | 42629145 | PubTator, text mining | PubMed |
| New ideas about mechanism in APOL1 kidney disease. | Kidney Int | 2026 | 42624538 | PubTator, text mining | PubMed |
| Chronic kidney disease risk stratification using a proteomic risk score in apolipoprotein L1-mediated kidney disease. | Kidney Int | 2026 | 42601028 | PubTator, text mining | PubMed |
| Letter by Hu et al Regarding Article, "Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage". | Circulation | 2026 | 42574520 | PubTator, text mining | PubMed |
| Response by Poudel and Susztak to Letter Regarding Article, "Cell-Specific Inducible Human APOL1 Risk Variant Expression in Mice Causes Hypertension and Renal Damage". | Circulation | 2026 | 42574518 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8542/papers